You are here
Home > Medibio Limited

Medibio Signs Insurance Company AIA Australia Ltd (AIAA) For an Exclusive Pilot Program For ilumen™

SYDNEY, Australia and MINNEAPOLIS, Nov. 27, 2018 (GLOBE NEWSWIRE) — Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company announces that it has signed an exclusive agreement with AIAA to undertake a pilot program for the latest release of its corporate health program, ilumen™. AIAA is one of Australia’s leading life […]

Medibio Broadens Opportunities with Compatibility to Fitbit Wearable Devices for Mental Health Measurement

Fitbit joins Apple Watch, Garmin and others allowing users to help process biometric data for an objective view of mental health SYDNEY, Australia and MINNEAPOLIS, June 13, 2018 (GLOBE NEWSWIRE) — Medibio Limited  (ASX:MEB) (OTCQB:MDBIF), the world leader in objective measurement technology for mental health, has recently enhanced the compatibility of its mobile app product […]

Medibio Receives CE Certification

CE certification opens doors for further commercialization SYDNEY, Australia and MINNEAPOLIS, May 02, 2018 (GLOBE NEWSWIRE) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, is pleased to confirm it has received CE (Conformité Européenne) Marking certification for its first release technology product and platform. Demonstrating that the product complies […]

Medibio Launches Global Corporate Mental Health Product

Release of first commercially available mental health technology product Notable existing support from key Australian companies Provide organizations with cost savings by reducing mental health burden SYDNEY, Australia and MINNEAPOLIS, April 30, 2018 (GLOBE NEWSWIRE) — Medibio Limited (MEB or the Company)(ASX:MEB)(OTCQB:MDBIF), a mental health technology company confirms the launch and release of the Company’s […]

Medibio Announces ISO 13485 Certification

SYDNEY, Australia and MINNEAPOLIS, Jan. 10, 2018 (GLOBE NEWSWIRE) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF) has received a Certificate of Compliance certifying that the Company’s Quality Management System complies with the requirements of ISO 13485.  This also includes conformance with the Canadian Medical Device Conformity Assessment System (CMDCAS). The certification was issued […]

Mayo Clinic to begin Prospective Clinical Study with Medibio Technology for Expanded Market Opportunities

Study designed to determine differential diagnosis in depression patients Study designed to monitor patient data following pharmacological treatment SYDNEY, Australia and MINNEAPOLIS, Dec. 14, 2017 (GLOBE NEWSWIRE) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company that has pioneered the use of objective biometrics to assist in the screening, diagnosing, […]

Medibio completes heavily oversubscribed institutional placement for $13.9 million to accelerate commercialisation

Highlights: Placement completed, with oversubscriptions accepted up to $13.9 Million Fidelity Investments follows on to maintain 10.6% ownership of the Company IFM Investors and Regal FM to become substantial shareholders post-transaction Medibio now fully funded to pursue aggressive commercialisation and IP strategy SYDNEY, Australia and MINNEAPOLIS, Oct. 12, 2017 (GLOBE NEWSWIRE) — Medibio Limited (ASX:MEB)(OTCQB:MDBIF) […]

Top